Effect of APOE alleles on the glial transcriptome in normal aging and Alzheimer's disease.

Computational Interspecies Translation Between Alzheimer's Disease Mouse Models and Human Subjects Identifies Innate Immune Complement, TYROBP, and TAM Receptor Agonist Signatures, Distinct From Influences of Aging.

Longitudinal differences in everyday preferences: Comparisons between people with cognitive impairment and their care partners.

Synaptic proteins associated with cognitive performance and neuropathology in older humans revealed by multiplexed fractionated proteomics.

Systematic in silico analysis of clinically tested drugs for reducing amyloid-beta plaque accumulation in Alzheimer's disease.

Genome-encoded cytoplasmic double-stranded RNAs, found in C9ORF72 ALS-FTD brain, propagate neuronal loss.

Impairment of visual cortical plasticity by amyloid-beta species.

An integrated genomic approach to dissect the genetic landscape regulating the cell-to-cell transfer of Îą-synuclein.

Visit-to-Visit Blood Pressure Variability, Neuropathology, and Cognitive Decline.

Cytoplasmic Mislocalization of RNA Polymerase II Subunit RPB1 in Alzheimer Disease Is Linked to Pathologic Tau.

Alzheimer disease.

Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons.

Association of APOE Genotype With Heterogeneity of Cognitive Decline Rate in Alzheimer Disease.

Kinetics of tau aggregation reveals patient-specific tau characteristics among Alzheimer's cases.

Apolipoprotein E4 Reduction with Antisense Oligonucleotides Decreases Neurodegeneration in a Tauopathy Model.